loperamide has been researched along with ceruletide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldassarre, G; Calo' Gabrieli, G; Palasciano, G; Portincasa, P; Velardi, A | 1 |
| Auernhammer, CJ; Lehnert, P; Müller, OA; Riepl, RL; Schopohl, J; Stalla, GK | 1 |
| Auernhammer, CJ; Beier, G; Lehnert, P; Reichardt, B; Riepl, RL; Schopohl, J; Stalla, GK | 1 |
1 trial(s) available for loperamide and ceruletide
| Article | Year |
|---|---|
Suppression of vagus-mediated pancreatic polypeptide release by the mu-opiate receptor agonist loperamide in man.
Topics: Adult; Bethanechol; Ceruletide; Corticotropin-Releasing Hormone; Humans; Loperamide; Male; Pancreatic Polypeptide; Receptors, Opioid, mu; Vagus Nerve | 1996 |
2 other study(ies) available for loperamide and ceruletide
| Article | Year |
|---|---|
[Effect of loperamide on the emptying of the gallbladder induced by caerulein].
Topics: Adult; Ceruletide; Gallbladder; Humans; Loperamide; Male; Piperidines | 1987 |
In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide.
Topics: Adrenocorticotropic Hormone; Adult; Ceruletide; Drug Interactions; Humans; Hydrocortisone; Loperamide; Male; Naloxone; Placebos; Receptors, Opioid, mu | 1994 |